MRD Reference Standards – For Ultra-Low Frequency ctDNA Detection
40+ pathogenic variants across 30+ genes, validated down to 0.005% VAF for MRD research
Product Center
Product Introduce
CB-Gene’s Package-Ref™ MRD Cocktail Reference Standard is designed specifically for ultra-low frequency ctDNA detection. It contains 30+ genes and 40+ pathogenic/likely pathogenic variants, including SNVs, insertions, deletions, and fusions. Using optimized ddPCR with >6000 copies per well, we have precisely characterized variants at 0.5% VAF, with serial dilution validation down to 0.05% and 0.005% VAF – levels that simulate real-world MRD detection challenges (NSCLC requires stable detection of ≥0.02% ctDNA).
Product Advantages
Our HRD Reference Standards to ensure the accuracy and reproducibility of HRD testing in clinical diagnostics and research, standardized reference materials are essential.
40+ pathogenic variants
Across 30+ genes, all with clinical significance (Pathogenic/Likely Pathogenic).
Diverse mutation types
Includes SNVs, insertions, deletions, frameshift, in-frame, nonsense, missense, splice-site, and fusions.
Serial dilution ready
High-frequency anchor variants (e.g., BRAF V600E at 5%) enable accurate dilution factor verification for 0.05% and 0.005% levels.
Ultra-low frequency validation
ddPCR-characterized at 0.5% VAF; dilution-validated at 0.05% and 0.005% VAF.
High-copy ddPCR calibration
>6000 copies per well at 0.5% to distinguish true positives from LOB; >12,000 copies for ultra-low frequency validation.
Dual-route compatible
Suitable for both tumor-informed assays (personalized panels) and tumor-agnostic assays (fixed panels).
Application
MRD Assay Development
Ultra-Low Frequency LoD
Daily Quality Control
Company Advantage
Expertise in reference standards – CB-Gene specializes in oncology molecular diagnostics with ISO‑certified production and patented technology.
Scientific Quality Management
With our ISO9001 certification, we adhere to a stringent quality management system, ensuring that all our products meet the highest standards of accuracy, stability, and consistency.
Ultra-low frequency expertise
Proprietary ddPCR calibration protocols achieve robust characterization at 0.005% VAF.
Specialized in IVD reference standards
CB-Gene focuses on positive reference panels, LoD standards, and precision controls for diagnostic development.
40+ clinically relevant variants
All variants are pathogenic/likely pathogenic with clear pathological grading significance.
Customizable formats
Art-base and Nat-base options; gDNA, FFPE, or ctDNA formats available upon request.
Experienced and Skilled Team
Backed by a talented team of experts, we leverage advanced technology and extensive experience to drive innovation in molecular diagnostics, ensuring we stay at the forefront of the industry.
Dedicated technical support
Free pre- and post-sales assistance for assay integration and troubleshooting.
Comprehensive Product Range
We offer a complete set of reference materials, including SNP, Indel, CNV, Fusion, NIPT, and more, covering a wide array of diagnostic needs and offering customized services for a variety of applications.
Contact Us
We're here to assist you! Whether you have questions about our products, services, or need technical support, our team is ready to provide you with the information you need. Reach out to us today!
FAQs
Related Blogs
ATP7B Reference Standards for Multi-Platform Wilson Disease Assay Validation
For laboratories developing and validating genetic tests for Wilson disease (WD), selecting appropriate ATP7B reference standards is an important part of establishing a controlled and reproducible assay. Wilson disease testing may use Sanger sequencing, quantitative real-time PCR (qPCR), droplet digital PCR (ddPCR), or targeted next-generation sequencing (NGS). Each workflow requires well-characterized genomic DNA reference materials to evaluate analytical performance, monitor run-to-run consistency, and support reliable ATP7B variant detection and genotyping. Suitable ATP7B reference standards should have clearly defined genotypes and variant identities, a relevant sample matrix, compatibility with the intended method, and characteristics aligned with the laboratory's validation plan. This article reviews the principal considerations when selecting ATP7B reference standards for multi-platform Wilson disease assay validation.
Read More
PSMA IHC Control Standards for IHC Assay Development and Quality Control
PSMA IHC control standards are critical reference materials for prostate cancer pathological diagnosis and targeted therapy testing. Featuring positive/negative 2‑in‑1 FFPE tissue design, they support simultaneous positive control, negative control, background evaluation, and staining specificity verification. Suitable for assay development, inter‑batch reproducibility monitoring, routine QC, and external quality assessment.
Read More
HLA Reference Standards for Assay Validation and Quality Control: A Practical Guide
HLA genotyping assays must deliver accurate, reproducible, and clearly interpretable results across different samples, reagent lots, operators, instruments, and laboratories. This requirement is especially important because HLA genes are highly polymorphic, and even a small difference in amplification, sequencing, allele assignment, or result interpretation may affect the final genotype call.
Read More
PCR-SSP, PCR-SBT, Sanger, NGS, or TGS: Which HLA Typing Method Fits Your Assay?
HLA typing methods differ in the way they detect alleles, the amount of sequence information they generate, the number of loci they can process, and the level of laboratory infrastructure they require. A method that works well for a rapid, targeted HLA test may not be suitable for a high-resolution transplantation workflow or a multi-locus research panel.
Read More
Get Touch With Us
Contact Info
Have questions or need assistance? We're here to help! Reach out to our team, and we'll provide the support you need.
